Are Ocular and Serum Half-Lives After Ranibizumab Intravitreal Injection Dependent on Dose?

Saved in:
Bibliographic Details
Published in:Translational vision science & technology 2023-04, Vol.12 (4), p.9-9
Main Authors: van Donge, Tamara, Brizzi, Francesco, Caruso, Antonello, Fueth, Matthias, Steiert, Bernhard
Format: Article
Language:English
Subjects:
Angiogenesis Inhibitors - therapeutic use
Bevacizumab
Eye
Intravitreal Injections
Letters to the Editor
Ranibizumab
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2164-2591
2164-2591
DOI:10.1167/tvst.12.4.9